ABOS - Acumen Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABOS is currently covered by 6 analysts with an average price target of $7.77. This is a potential upside of $6.77 (677%) from yesterday's end of day stock price of $1.

Acumen Pharmaceuticals's activity chart (see below) currently has 14 price targets and 26 ratings on display. The stock rating distribution of ABOS is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ABOS is $11, Lowest price target is $6, average price target is $11.33.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 28-Mar-2025. First documented stock forecast 26-Jul-2021.

Currently out of the existing stock ratings of ABOS, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$9.92 (918.52%)

1 months 11 days ago
(28-Mar-2025)

0/8 (0%)

$9.81 (824.37%)

Buy

$6

$4.92 (455.56%)

$15

8 months 24 days ago
(15-Aug-2024)

0/3 (0%)

$3.42 (132.56%)

Buy

$11

$9.92 (918.52%)

$15

1 years 1 months 12 days ago
(27-Mar-2024)

0/2 (0%)

$6.9 (168.29%)

Buy

$13

$11.92 (1103.70%)

$13

1 years 9 months ago
(09-Aug-2023)

0/5 (0%)

$6.22 (91.74%)

Buy

$14

$12.92 (1196.30%)

$16

1 years 9 months 19 days ago
(20-Jul-2023)

0/3 (0%)

$6.69 (91.52%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABOS (Acumen Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?

GEOFF MEACHAM

Which analyst has the current lower performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?

PETE STAVROPOULOS

Which analyst has the most public recommendations on ABOS (Acumen Pharmaceuticals)?

Geoff Meacham works at BAML and has 12 price targets and 9 ratings on ABOS

Which analyst is the currently most bullish on ABOS (Acumen Pharmaceuticals)?

Geoff Meacham with highest potential upside - $12.92

Which analyst is the currently most reserved on ABOS (Acumen Pharmaceuticals)?

Colin Bristow with lowest potential downside - $4.92

Acumen Pharmaceuticals in the News

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

In this article, we will take a look at the 13 best penny stocks to buy according to billionaire Ken Griffin. To see more such companies, go directly to 5 Best Penny Stocks to Buy According to Billionaire Ken Griffin. The markets were off to an impressive start in 2024, driven by expectations that the...

Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot

As investors, we are often looking to diversify our portfolios. Especially with the wild AI craze in the past year, many investors already hold positions in AI or other technology companies. Adding a variety of stocks from different sectors in your portfolio can help reduce risk. It lessens your dependence on returns in one sector....
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?